Gantra 10MG Tablet (14’s) is a medication that contains Vericiguat as its active ingredient, specifically formulated to manage heart failure. Each tablet delivers a precise dosage of 10 mg of Vericiguat, which is designed to improve the heart’s ability to pump blood effectively. This medication is particularly beneficial for patients with chronic heart failure, especially those who have recently experienced a worsening of their condition. Gantra works by enhancing the sensitivity of soluble guanylate cyclase, an enzyme that plays a crucial role in the cardiovascular system, leading to vasodilation and improved blood flow. The formulation is available in a convenient pack of 14 tablets, making it easy for patients to adhere to their treatment regimen. As a result, Gantra 10MG Tablet is an essential option for individuals seeking to manage their heart failure symptoms and improve their overall quality of life.

Gantra 5MG Tablet (14’s) is a medication that contains Vericiguat as its active ingredient, specifically formulated to aid patients suffering from heart failure. This drug is designed to improve the quality of life for individuals with chronic heart failure, particularly those who have recently experienced a worsening of their condition. Vericiguat works by enhancing the sensitivity of soluble guanylate cyclase, a receptor that plays a crucial role in the cardiovascular system. This leads to increased levels of cyclic guanosine monophosphate (cGMP), resulting in vasodilation and improved blood flow. The composition of Gantra 5MG Tablet includes 5 mg of Vericiguat, and it is packaged in a convenient 14-tablet blister pack, making it easy for patients to manage their medication regimen. Overall, Gantra serves as an essential therapeutic option for managing heart failure, helping to alleviate symptoms and improve overall heart function.

Gantra 2.5MG Tablet (14’s) is a medication that contains Vericiguat as its active ingredient, with each tablet delivering a dosage of 2.5 mg. This drug is primarily indicated for the treatment of heart failure, particularly in patients with worsening chronic heart failure or those who have recently been hospitalized for heart failure exacerbations. Vericiguat works by enhancing the sensitivity of soluble guanylate cyclase, a receptor that plays a crucial role in the nitric oxide signaling pathway, leading to vasodilation and improved blood flow. The formulation of Gantra is designed to provide effective management of heart failure symptoms, ultimately improving the quality of life for patients. It is essential for patients to follow their healthcare provider’s instructions regarding the use of this medication to achieve optimal therapeutic outcomes.